Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
NLSP
Fundamentals

Nls Pharmaceutics Ltd.

NLSP

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

1.19M
▼-653.18k▼-35.37%
6 Months Change

Liabilities

10.46M
▼-218.49k▼-2.05%
6 Months Change

Free Cash Flow

-14.98M
▼-14.98M-∞%
-

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-05-15
Form 20-F
ID: 0001213900-24-043570
2023-05-05
Form 20-F
ID: 0001213900-23-036920
2022-03-24
Form 20-F
ID: 0001213900-22-014905
2021-05-14
Form 20-F
ID: 0001213900-21-026511